Chemoinformaics analysis of 3,8-DIHYDROXY-1-METHYLANTHRAQUINONE-2-CARBOXYLIC-ACID
| Molecular Weight | 298.25 | nRot | 1 |
| Heavy Atom Molecular Weight | 288.17 | nRig | 19 |
| Exact Molecular Weight | 298.048 | nRing | 3 |
| Solubility: LogS | -3.583 | nHRing | 0 |
| Solubility: LogP | 3.785 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 38.1999 |
| nHD | 3 | BPOL | 12.6361 |
| QED | 0.632 |
| Synth | 2.426 |
| Natural Product Likeliness | 1.257 |
| NR-PPAR-gamma | 0.891 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.011 |
| Pgp-sub | 0.002 |
| HIA | 0.105 |
| CACO-2 | -5.482 |
| MDCK | 0.0000075 |
| BBB | 0.043 |
| PPB | 0.989226 |
| VDSS | 0.436 |
| FU | 0.0140005 |
| CYP1A2-inh | 0.42 |
| CYP1A2-sub | 0.084 |
| CYP2c19-inh | 0.035 |
| CYP2c19-sub | 0.045 |
| CYP2c9-inh | 0.493 |
| CYP2c9-sub | 0.063 |
| CYP2d6-inh | 0.11 |
| CYP2d6-sub | 0.107 |
| CYP3a4-inh | 0.144 |
| CYP3a4-sub | 0.076 |
| CL | 1.11 |
| T12 | 0.362 |
| hERG | 0.027 |
| Ames | 0.901 |
| ROA | 0.032 |
| SkinSen | 0.608 |
| Carcinogencity | 0.705 |
| EI | 0.851 |
| Respiratory | 0.09 |
| NR-Aromatase | 0.021 |
| Antiviral | Yes |
| Prediction | 0.78752 |